Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.
about
Pharmacological treatment for Buerger's diseasePharmacological treatment for Buerger's diseaseProstanoids for intermittent claudicationPharmacological treatment for Buerger's diseaseProstacyclin for pulmonary hypertension in adultsProstanoids for intermittent claudicationPhosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMPOutcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprostArrhythmias in pulmonary arterial hypertensionLong term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusionInhaled iloprost in pulmonary arterial hypertension.Natural course of intra-articular shifting bone marrow edema syndrome of the knee.The effect of epoprostenol on platelet activation and consumption during experimental extracorporeal perfusion.Effective prevention of pseudothrombocytopenia in feline blood samples with the prostaglandin I2 analogue Iloprost.Improvement in cholesterol emboli syndrome after iloprost therapy.Inhibitors of platelet signal transduction as anti-aggregatory drugs.Successful treatment of ergotism with Iloprost--a case report.The role of inhaled prostacyclin in treating acute respiratory distress syndrome.New treatments for pulmonary arterial hypertension.Efficiency of iloprost treatment for osseous malperfusion.Modulation of the intramedullary pressure responses by calcium dobesilate in a rabbit knee model of osteoarthritis.Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.Review of inhaled iloprost for the control of pulmonary artery hypertension in childrenCurrent and future therapeutic options for persistent pulmonary hypertension in the newborn.Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension.Bone marrow lesions and subchondral bone pathology of the knee.Effect of prostaglandin I2 analogs on monocyte chemoattractant protein-1 in human monocyte and macrophage.Intravenous iloprost for treatment of critical limb ischemia in patients unsuitable for revascularization.[Bone marrow edema and atraumatic necrosis of the femoral head : Therapy].Infusion, core decompression, or infusion following core decompression in the treatment of bone edema syndrome and early avascular osteonecrosis of the femoral head.Effects of iloprost on pain-free walking distance and clinical outcome in patients with severe stage IIb peripheral arterial disease: the FADOI 2bPILOT Study.Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia.Treatment of chronic ischaemia of a replanted thumb with iloprost.Polyarteritis nodosa resistant to conventional treatment in a pediatric patient.User preference for a portable syringe pump for iloprost infusion.Effects of alprostadil and iloprost on renal, lung, and skeletal muscle injury following hindlimb ischemia-reperfusion injury in rats.Iloprost drug delivery during infant conventional and high-frequency oscillatory ventilation.Bone Marrow Aspirate Concentrate in Combination With Intravenous Iloprost Increases Bone Healing in Patients With Avascular Necrosis of the Femoral Head: A Matched Pair Analysis.The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgery.
P2860
Q24186035-C124DFCA-8181-4FB7-841D-423706C290C5Q24186181-65BC8CA8-D0EB-4A81-8FB8-480EE710A29EQ24197689-4AD11192-E180-4C4F-935A-0FC3AB9C0238Q24198267-8372243B-4AF4-467E-AB62-65136DC46B42Q24246933-643881E6-9B4B-4930-AA52-441A4A21EBDEQ24247757-176654BD-7821-4BC3-B15F-3D1ED42565ABQ24336559-F77184B6-B742-4F20-B70F-DEF09E2B22BFQ24658235-9520D865-F557-4776-8653-03D5F99DCCF8Q27025034-E68DF5C0-4FFE-4BB2-A195-41C0CD0396C9Q28346468-0E176B36-626F-4923-B05E-CB2FFD4F4D8CQ30437211-57F271F2-E34C-486D-9A8B-F347006DB37BQ33327747-8F56C960-0DEA-4098-B9B4-F5A34C68C76CQ33330641-B22DEC23-35C0-43A7-BFE4-3B57B9566EDCQ33424936-D8589E02-6FEE-45A2-BDC5-668CED85F40EQ33953275-C30EF3AE-9CDB-4141-92E2-D5300EAFA3A0Q34232030-3FC4D9D9-A39B-4151-B71D-3C331EDCFBBAQ34472309-D94C6709-CEBA-49A5-A1D2-11868311DC52Q34490411-764C4787-4F97-436E-9255-56A71C3B479EQ34625826-6AEA0C64-602A-4894-B1EA-43186B18041CQ34828186-15ABEEA8-1868-42DB-991F-150A25923180Q35624452-BA6D6906-9DAB-4E53-B898-B50494219A5BQ36993305-FABC7848-27C8-4F16-AEF4-64A2382F7C14Q37402417-5FC2B6F7-D2A9-4F29-80E4-84C234340777Q37479077-EA2E5893-B12B-4A20-93CC-FDDD0B592535Q37763202-3E20D985-C152-49A7-B28F-E5C7E17F5F9FQ37960635-3B3086F8-DD6B-404D-B528-B94A44AEDBF1Q38807786-81B21A9B-2D67-424B-A6A6-6B6C6AA439F9Q38963041-50D64FB9-A504-49CE-AAF5-8D93F025E792Q39113162-D3B10851-A132-48A5-B4A5-F55E6CC1B2C7Q39185286-232FE621-BA90-49D4-896D-84DD07C1E242Q39235755-23B15843-7C76-4A8E-8C2D-D0FF1C786AC6Q39337732-8620EDED-5DD9-466F-A65E-0C70802EE975Q39346326-2157C3E4-16A8-4ECC-98C1-88D2848662F6Q39632701-22B11EA1-C3DE-4FB1-8A17-175853682224Q39792282-A64BBE40-3563-4B81-B1AB-B5D3137A150BQ40286785-71FCDFF7-83D1-45D1-B13C-0ACE12BFE172Q40965296-0B57B49C-2B33-4E7C-872C-0BDB1F8F37BAQ41166895-B32CDF2F-9EC1-4B47-BE66-AC877191DD8DQ42290729-79830F10-C99D-4ADF-8C8C-70DCAF3C536DQ42692275-85F0C3E8-9DFA-4D0D-AF88-0B3749E05353
P2860
Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Iloprost. A review of its phar ...... poreal circulation procedures.
@ast
Iloprost. A review of its phar ...... poreal circulation procedures.
@en
type
label
Iloprost. A review of its phar ...... poreal circulation procedures.
@ast
Iloprost. A review of its phar ...... poreal circulation procedures.
@en
prefLabel
Iloprost. A review of its phar ...... poreal circulation procedures.
@ast
Iloprost. A review of its phar ...... poreal circulation procedures.
@en
P1433
P1476
Iloprost. A review of its phar ...... poreal circulation procedures.
@en
P304
P356
10.2165/00003495-199243060-00008
P577
1992-06-01T00:00:00Z
P6179
1003142073